{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:56:33Z","timestamp":1790751393475,"version":"4.1.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence regarding the association between Parkinson\u2019s disease (PD) and cardio-cerebrovascular risk remains conflicting, and it is unclear whether the dynamic progression of carotid atherosclerosis in PD patients differs from that in non-PD individuals. This study aimed to compare the progression of carotid atherosclerosis over a 1-year follow-up between PD patients and matched controls, and to investigate whether PD influences this progression independently of traditional cardiovascular risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective cohort study ultimately included 61 PD patients and 59 age- and sex-matched non-PD controls. Carotid ultrasound was performed at baseline and at the 1-year follow-up. The primary outcome was the annual change in total plaque area (\u0394TPA), with plaque progression defined as \u0394TPA \u2265 0.05 cm\n                      <jats:sup>2<\/jats:sup>\n                      . Multivariable logistic regression models, adjusting for diabetes, smoking, total cholesterol, and low-density lipoprotein cholesterol (LDL-C), were used to assess the independent association between PD status and plaque progression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At baseline, carotid intima-media thickness and TPA were significantly lower in the PD group than in the control group (both\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). After 1 year, \u0394TPA was significantly smaller in the PD group (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001), and the incidence of plaque progression was 6.56% in PD patients versus 25.42% in controls. Multivariable regression analysis showed that PD status was a protective factor against atherosclerosis progression (adjusted OR = 0.27, 95% CI: 0.074\u20130.984,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.047). Within the PD group, no significant associations were observed between plaque progression and disease-specific factors such as disease duration, motor severity, or levodopa equivalent daily dose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Carotid atherosclerosis progression is significantly slower in PD patients than in non-PD individuals, and this effect is independent of traditional cardiovascular risk factors. These findings suggest that PD patients may exhibit a \u201cvascular protective phenotype,\u201d and that a unique shared regulatory network may exist between neurodegenerative processes and peripheral vascular homeostasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2026.1928073","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:04:48Z","timestamp":1790748288000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Carotid atherosclerosis progression in patients with Parkinson\u2019s disease: a prospective cohort study"],"prefix":"10.3389","volume":"18","author":[{"given":"Siyu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Qilu Hospital of Shandong University, Jinan","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Qilu Hospital of Shandong University, Jinan","place":["Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbo","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1111\/ene.14938","article-title":"Cardiovascular and cerebrovascular risk markers in Parkinson\u2019s disease: Results from a case-control study.","volume":"28","author":"Alves","year":"2021","journal-title":"Eur. J. Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/87895","article-title":"The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor\/vascular endothelial growth factor.","volume":"7","author":"Basu","year":"2001","journal-title":"Nat. Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/mds.28357","article-title":"The vasomotor response to dopamine is altered in the rat model of l-dopa-induced dyskinesia.","volume":"36","author":"Booth","year":"2021","journal-title":"Mov. Disord"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/mds.28551","article-title":"Type 2 diabetes as a determinant of Parkinson\u2019s disease risk and progression.","volume":"36","author":"Chohan","year":"2021","journal-title":"Mov. Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCRESAHA.119.314929","article-title":"Lipids, Apolipoproteins, and the risk of parkinson disease.","volume":"125","author":"Fang","year":"2019","journal-title":"Circ. Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis.","volume":"120","author":"F\u00f6rstermann","year":"2017","journal-title":"Circ. Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"838","DOI":"10.3109\/00207454.2014.979288","article-title":"The serum lipid profile of Parkinson\u2019s disease patients: A study from China.","volume":"125","author":"Guo","year":"2015","journal-title":"Int. J. Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41531-026-01260-8","article-title":"Super-resolution ultrasound imaging indirectly reveals neurovascular uncoupling in substantia nigra of a Parkinson\u2019s disease model.","volume":"12","author":"Hou","year":"2026","journal-title":"NPJ Parkinsons Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1284826","DOI":"10.3389\/fcvm.2023.1284826","article-title":"Association between Parkinson\u2019s disease and the risk of adverse cardiovascular events: A systematic review and meta-analysis.","volume":"10","author":"Hu","year":"2023","journal-title":"Front. Cardiovasc. Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e213931","DOI":"10.1212\/WNL.0000000000213931","article-title":"Midlife vascular risk factors, Parkinson disease, and parkinson disease-dementia: The ARIC study.","volume":"105","author":"Johri","year":"2025","journal-title":"Neurology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1007\/s00415-023-11622-4","article-title":"The effect of levodopa treatment on vascular endothelial function in Parkinson\u2019s disease.","volume":"270","author":"Kim","year":"2023","journal-title":"J. Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuroscience.2024.09.015","article-title":"Impact of 6-hydroxydopamine on agonist-induced human platelet functional parameters: An explanation for platelet impairment in Parkinson\u2019s disease.","volume":"559","author":"Kumar Beura","year":"2024","journal-title":"Neuroscience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.2147\/NDT.S553623","article-title":"Diagnostic value of carotid intima-media thickness combined with periventricular white matter hyperintensities for mild cognitive impairment in Parkinson\u2019s disease.","volume":"21","author":"Li","year":"2025","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2454","DOI":"10.1002\/brb3.2454","article-title":"Association of serum cholesterol with Parkinson\u2019s disease in a cohort of statin-free individuals.","volume":"12","author":"Lv","year":"2022","journal-title":"Brain Behav"},{"key":"B15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-017-0904-4","article-title":"Co-morbidity and polypharmacy in Parkinson\u2019s disease: Insights from a large scottish primary care database.","volume":"17","author":"McLean","year":"2017","journal-title":"BMC Neurol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1096\/fj.201601131R","article-title":"Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma.","volume":"31","author":"Osinga","year":"2017","journal-title":"FASEB J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jcmg.2023.09.005","article-title":"Carotid plaque-RADS: A novel stroke risk classification system.","volume":"17","author":"Saba","year":"2024","journal-title":"JACC Cardiovasc. Imaging"},{"key":"B18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10456-016-9531-8","article-title":"Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis.","volume":"20","author":"Sarkar","year":"2017","journal-title":"Angiogenesis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1161\/01.str.0000042207.16156.b9","article-title":"Carotid plaque area: A tool for targeting and evaluating vascular preventive therapy.","volume":"33","author":"Spence","year":"2002","journal-title":"Stroke"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1161\/01.str.21.10.1395","article-title":"Stroke and its modification in Parkinson\u2019s disease.","volume":"21","author":"Struck","year":"1990","journal-title":"Stroke"},{"key":"B21","doi-asserted-by":"publisher","first-page":"02127","DOI":"10.3389\/fimmu.2020.02127","article-title":"Assessing genetic overlap between platelet parameters and neurodegenerative disorders.","volume":"11","author":"Tirozzi","year":"2020","journal-title":"Front. Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease.","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"B23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","article-title":"Parkinson\u2019s disease genetics and pathophysiology.","volume":"44","author":"V\u00e1zquez-V\u00e9lez","year":"2021","journal-title":"Annu. Rev. Neurosci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ejcn.2014.259","article-title":"Cardiovascular risk factors and the risk of Parkinson\u2019s disease.","volume":"69","author":"Vikdahl","year":"2015","journal-title":"Eur. J. Clin. Nutr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/ars.2020.8106","article-title":"Renal dopamine receptors and oxidative stress: Role in hypertension.","volume":"34","author":"Yang","year":"2021","journal-title":"Antioxid. Redox. Signal"},{"key":"B26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ultrasmedbio.2020.09.025","article-title":"Ultrasound-based carotid plaque characteristics help predict new cerebral ischemic lesions after endarterectomy.","volume":"47","author":"Zhou","year":"2021","journal-title":"Ultrasound Med. Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13089-021-00218-6","article-title":"Carotid intima-media thickness and cardiovascular risk factors in healthy volunteers.","volume":"13","author":"Zyriax","year":"2021","journal-title":"Ultrasound J"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1928073\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:04:49Z","timestamp":1790748289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2026.1928073\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":27,"alternative-id":["10.3389\/fnagi.2026.1928073"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2026.1928073","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1928073"}}